In the News

Share

Connect with us

Stay Informed.

Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
COVID-19: Information for Patients and Caregivers

We're here for you, and continue to provide cancer care to new and current patients. Learn about our response to COVID-19.

What you need to know

1664 News Items found
In Brief
A fluorescent image of cells undergoing differentiation in a mouse model.
Cancer Stem Cells’ Reliance on a Key Amino Acid Could Be an Exploitable Weakness

The discovery links metabolism to the way cancer stem cells form tumors.
Alexander Drilon, MD
Targeted Therapy Selpercatinib Approved for Lung and Thyroid Cancers With RET Gene Mutations or Fusions

The U.S. Food and Drug Administration (FDA) recently granted accelerated approval to selpercatinib (Retevmo™) for lung and thyroid cancers with RET (REarranged during Transfection) gene mutations or fusions.
Katherine High, MD
MSK Science Spotlight: Gene Therapy for Genetic Disease

The May 20 installment of “MSK Science Spotlight” will feature guest speaker, Katherine High, MD, Professor Emerita, Perelman School of Medicine of the University of Pennsylvania; Co-founder and former President and Head of R&D, Spark Therapeutics.
In the Clinic
Lisa Toth donates plasma with help from Anli Chang
Exploring the Potential of Convalescent Plasma for COVID-19 Treatment

Learn about a clinical trial at Memorial Sloan Kettering that is using plasma donated by MSK employees who have recovered from COVID-19.
Radiation oncology
Short Course Radiation Provides Benefits to Patients During COVID-19 Pandemic

In order to preserve healthcare resources and provide exceptional care, our teams have been working together to develop new and innovative ways to treat our patients during the COVID-19 pandemic. MSK radiation oncologists rapidly re-evaluated our rectal cancer practice policies during this public health emergency.
In the Clinic
Andrew Kung
Study Shows COVID-19 Not a Significant Threat to Kids with Cancer

Learn about a new study led by MSK that suggests that children with cancer are no more likely than other kids to be infected with COVID-19 or to have severe symptoms when infected.
In the Lab
Jedd Wolchok in his lab
The Many Faces of the Immune Response to COVID-19: How Cancer Research Is Contributing to a Deeper Understanding

During the COVID-19 pandemic, MSK doctors and researchers are applying their knowledge about immunology toward the development of treatments.
Dr. Andrew Kung, MD, PhD, Chair of MSK Kids
MSK Kids Study: Children with Cancer are Not at a Higher Risk for COVID-19 Infection or Morbidity

MSK Kids researchers publish report of screening and testing for COVID-19 in pediatric cancer patients in New York City.
Carl June, MD
Science Spotlight to Feature Updates on CAR T Cells from Carl June, MD

The May 13 installment of “MSK Science Spotlight” will feature co-winner of The Society of Memorial Sloan Kettering Prize, Carl June, MD.
Jeffrey Drebin
Managing Cancer Surgery Amid COVID-19

Cancer doesn’t stop for a pandemic, but as local governments around the nation mandated the stoppage of elective surgery, Memorial Sloan Kettering Cancer Center (MSK) surgeons had to consider several critical questions.